Article Details

Israeli Biotech Startup SpliSense Raises $28M For Cystic Fibrosis Therapeutics

Retrieved on: 2021-05-17 16:52:30

Tags for this article:

Click the tags to see associated articles and topics

Israeli Biotech Startup SpliSense Raises $28M For Cystic Fibrosis Therapeutics. View article details on hiswai:

Excerpt

Israeli biotech startup SpliSense, a pre-clinical developer of mRNA-altering therapies for cystic fibrosis (CF) and other genetic pulmonary diseases, ...

Article found on: nocamels.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up